Haoxi Health Technology Limited (HAO) P/E Ratio History
Historical price-to-earnings valuation from 2024 to 2025
Loading P/E history...
HAO Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Haoxi Health Technology Limited (HAO) trades at a price-to-earnings ratio of 0.7x, with a stock price of $0.71 and trailing twelve-month earnings per share of $0.09.
The current P/E is 100% below its 5-year average of 359.6x. Over the past five years, HAO's P/E has ranged from a low of 27.6x to a high of 691.7x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Communication Services sector median P/E of 15.4x, HAO trades at a 96% discount to its sector peers. The sector includes 108 companies with P/E ratios ranging from 0.1x to 179.7x.
Relative to the broader market, HAO trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our HAO DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
HAO P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $589M | 9.2Lowest | - | +225%Best | |
| $49B | 14.4 | 0.24Best | +20% | |
| $1B | 10.7 | - | -61% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
HAO Historical P/E Data (2024–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q2 | $3.75 | $0.14 | 27.6x | -92% | |
| FY2024 Q4 | Sun Jun 30 2024 00:00:00 GM | $133.50 | $0.19 | 691.7x | +92% |
Average P/E for displayed period: 359.6x
See HAO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HAO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HAO vs NFLX
Side-by-side business, growth, and profitability comparison vs Netflix, Inc..
Start ComparisonHAO — Frequently Asked Questions
Quick answers to the most common questions about buying HAO stock.
Is HAO stock overvalued or undervalued?
HAO trades at 0.7x P/E, below its 5-year average of 359.6x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does HAO's valuation compare to peers?
Haoxi Health Technology Limited P/E of 0.7x compares to sector median of 15.4x. The discount suggests lower growth expectations or higher risk.
What is HAO's PEG ratio?
HAO PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2024-2025.